Accelerate Ideas, Partnerships and Opportunities
Book your SLOT NOW
OTDC 2026
Oligonucleotide Therapeutics and Delivery Conference
March 23-24, 2026 | Rome, Italy
Website: oligo-nucleotide.com
31.05.2025 05:25 — 👍 0 🔁 1 💬 0 📌 0
Sciinov Group's
OTDC 2026
Oligonucleotide Therapeutics and Delivery Conference is all set to happen on March 23-24, 2026 as a hybrid event in Rome, Italy
Details: oligo-nucleotide.com
30.05.2025 06:23 — 👍 0 🔁 0 💬 0 📌 0
Sciinov group's
OTDC 2026
Oligonucleotide Therapeutics and Delivery Conference is all set to happen on
March 23-24, 2026 @Rome, Italy
Website: oligo-nucleotide.com
29.05.2025 05:45 — 👍 0 🔁 0 💬 0 📌 0
Join us on 23 March, 2026 at Rome, Italy
for the
OTDC 2026-
Oligonucleotide Therapeutics and Delivery Conference
Conference Website: oligo-nucleotide.com
28.05.2025 04:16 — 👍 0 🔁 0 💬 0 📌 0
ADD THESE DATES TO YOUR E-DIARY OR GOOGLE CALENDAR
OTDC 2026
Oligonucleotide Therapeutics and Delivery Conference
March 23-24, 2026 | Rome, Italy
Conference Website: oligo-nucleotide.com
27.05.2025 08:36 — 👍 0 🔁 0 💬 0 📌 0
Sciinov Group is proud to announce the Oligonucleotide Therapeutics and Delivery Conference, 23-24 March, 2026 in Rome, Italy.
Website: oligo-nucleotide.com
26.05.2025 11:33 — 👍 1 🔁 0 💬 0 📌 0
Assistant Professor @IRCM, @McGill Center for RNA Sciences, @UdeM.
RNA Biology, lncRNA, RNA Therapy, Genome Regulation sauvageaulab.org
Cancer & RNA splicing researcher (he/him)
https://mqvlab.com
Assistant Professor
Department of Immunology and Cell Biology
Université de Sherbrooke
Maître d’œuvre du développement de la génomique au Québec. The driving force behind the development of genomics in Québec. https://genomequebec.com/
Transforming genomics research into solutions for Canada | Transformer la recherche en génomique en solutions pour le Canada genomecanada.ca | genomecanada.ca/fr
Welcome to the McGill Human Genetics Student Society! We’re your window into groundbreaking research, innovative projects, and the vibrant voices of our academic community.
Multi-site, transformative preclinical evaluation of novel neurotherapeutics through a Government of Canada $24M New Frontiers In Research grant. Check out our website tridentpreclinicaltrials.org for more info or email info@tridentpreclinicaltrial.org!
Assistant Professor, Dept. Human Genetics, McGill University | elle/she/her
#NordicMade networking org intersecting #SiliconValley & #NewNordics: #cphftw #helyes #icemade #siliconfjord #sthlmtech #estotech #startinLatvia #LTstartups
Sausalito, CA, USA
https://koik.me/siliconvikings
Arrakis is on a path to bring powerful new RNA-targeted small molecule (rSM) therapies to millions of patients.
Redefining cancer immunotherapy with RNA technology.
At OligoTune, we're redefining cancer immunotherapy with RNA technology that reprograms the tumour microenvironment to target resistant tumours. With innovative, patient-centred treatments, we’re bringi
We distribute news based on information from press releases and other sources. #F4F
We love all things RNA! We from the Eric Miska lab run a monthly seminar series on topics related to RNA biology and chemistry. Sponsored by The RNA Society and Lexogen 🧬
https://www.ericmiskalab.org/cambridge-rna-club/
Genomics, bioinformatics & non-coding RNA
PI of the #RegRNALab @unswrna.bsky.social @unswbabs.bsky.social
Board member @iscb.bsky.social
Visited #Antarctica in 2025 as part of #HBTransform
ARC Future Fellow
🇲🇽/🇭🇲 #Latina
Opinions == mine
Professor University of Maryland, co-founder Silvec Biologics finding RNA solutions to plant diseases, love Plant Virology, author Real Science Behind The X-Files, and passionate about dressage!
Nucleic acid chemistry and RNA therapeutics at UMass Chan Medical School.
The RNA Therapeutics Institute (RTI) at UMass Chan Medical School. Uniting nucleic acid scientists w/clinicians to devise human therapies. Loving RNA since before it was cool. #RNATx2025
Group leader developing molecular therapies for inherited neurometabolic and retinal diseases at the Radboudumc 👁️🧪🧬
From Barcelona,📍based in Nijmegen
Next-generation RNA splicing modulation platform dedicated to transforming patient outcomes in severe genetic diseases #RNAtherapeutics #RNAsplicingmodulation #Pseudoexon #Parkinsons #Huntingtons
D2R | DNA to RNA is a research initiative at McGill University taking an inclusive Canadian approach to developing genomic-based #RNA therapies for rare diseases, infectious diseases and cancer.
www.mcgill.ca/dna-to-rna/